HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Riccardo Riccardi Selected Research

Optic Nerve Glioma

2/2016Nerve growth factor improves visual loss in childhood optic gliomas: a randomized, double-blind, phase II clinical trial.
4/2015Functional Loss of the Inner Retina in Childhood Optic Gliomas Detected by Photopic Negative Response.
7/2011Topical nerve growth factor as a visual rescue strategy in pediatric optic gliomas: a pilot study including electrophysiology.
5/2011Nerve growth factor eye drop administration improves visual function in a patient with optic glioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Riccardo Riccardi Research Topics

Disease

42Neoplasms (Cancer)
01/2021 - 10/2002
19Glioma (Gliomas)
01/2021 - 10/2002
11Neuroblastoma
01/2014 - 10/2005
10Medulloblastoma
01/2020 - 02/2009
6Ependymoma
02/2021 - 06/2004
6Primitive Neuroectodermal Tumors (PNET)
01/2020 - 02/2006
6Brain Neoplasms (Brain Tumor)
11/2013 - 06/2004
6Rhabdomyosarcoma
07/2012 - 08/2003
5Pain (Aches)
03/2014 - 03/2004
4Infections
04/2019 - 01/2013
4Hypersensitivity (Allergy)
01/2017 - 05/2002
4Optic Nerve Glioma
02/2016 - 05/2011
3Carcinogenesis
01/2021 - 02/2009
3Traumatic Brain Injuries (Traumatic Brain Injury)
01/2017 - 05/2008
3Vision Disorders (Hemeralopia)
02/2016 - 05/2011
3Sarcoma (Soft Tissue Sarcoma)
07/2012 - 08/2003
3Brain Injuries (Brain Injury)
11/2011 - 10/2005
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2011 - 12/2002
3Glioblastoma (Glioblastoma Multiforme)
01/2011 - 07/2006
2Birth Weight (Birth Weights)
01/2020 - 01/2018
2Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2020 - 01/2018
2Ewing Sarcoma (Sarcoma, Ewing)
01/2018 - 04/2012
2Melanoma (Melanoma, Malignant)
12/2016 - 04/2006
2Human Influenza (Influenza)
07/2014 - 12/2013
2Fever (Fevers)
12/2013 - 01/2013
2Nausea
11/2013 - 03/2013
2Lymphoma (Lymphomas)
11/2013 - 12/2006
2Anemia
08/2013 - 10/2002
2Cancer Pain
03/2013 - 01/2009
2Neoplasm Metastasis (Metastasis)
04/2012 - 08/2003
2Atrophy
07/2011 - 05/2011
2Coma (Comas)
04/2008 - 10/2005
2Carcinoma (Carcinomatosis)
07/2006 - 09/2003
2Astrocytoma (Pilocytic Astrocytoma)
06/2004 - 05/2002
2Atrioventricular Block
08/2003 - 01/2003

Drug/Important Bio-Agent (IBA)

12Nerve Growth Factor (NGF)IBA
01/2021 - 06/2004
11Pharmaceutical PreparationsIBA
02/2021 - 08/2003
9Temozolomide (Temodar)FDA LinkGeneric
01/2020 - 07/2006
6Irinotecan (Camptosar)FDA LinkGeneric
12/2012 - 09/2005
5Proteins (Proteins, Gene)FDA Link
02/2021 - 04/2008
5Phosphotransferases (Kinase)IBA
01/2021 - 10/2005
4Topotecan (Hycamtin)FDA LinkGeneric
01/2020 - 10/2005
4Carboplatin (JM8)FDA LinkGeneric
01/2017 - 05/2002
4Etoposide (VP 16)FDA LinkGeneric
08/2014 - 10/2002
4Antineoplastic Agents (Antineoplastics)IBA
10/2013 - 01/2005
4ErbB Receptors (EGF Receptor)IBA
09/2012 - 12/2006
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2021 - 07/2006
3Nerve Growth Factors (Neurotrophins)IBA
01/2021 - 06/2004
3Epidermal Growth Factor (EGF)IBA
11/2017 - 12/2008
3Ophthalmic Solutions (Eye Drops)IBA
02/2016 - 05/2011
3Platinum Compounds (Compounds, Platinum)IBA
01/2016 - 10/2013
3DNA (Deoxyribonucleic Acid)IBA
08/2014 - 07/2006
3Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
12/2013 - 06/2004
3CytokinesIBA
12/2013 - 05/2008
3Interleukin-6 (Interleukin 6)IBA
12/2013 - 05/2008
3Brain-Derived Neurotrophic Factor (BDNF)IBA
12/2013 - 06/2004
3Cisplatin (Platino)FDA LinkGeneric
11/2013 - 10/2002
3Methotrexate (Mexate)FDA LinkGeneric
10/2013 - 12/2002
3CamptothecinIBA
12/2012 - 10/2005
3Gefitinib (Iressa)FDA Link
09/2012 - 12/2008
3RetinoidsIBA
08/2012 - 03/2007
3Imatinib Mesylate (Gleevec)FDA Link
03/2007 - 10/2005
3TrabectedinIBA
09/2005 - 08/2003
2Protein Kinases (Protein Kinase)IBA
01/2021 - 09/2008
2NucleotidesIBA
07/2020 - 12/2006
2Surface-Active Agents (Surfactants)IBA
01/2020 - 01/2018
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2018 - 04/2012
2KetamineFDA LinkGeneric
03/2014 - 12/2011
2InterleukinsIBA
12/2013 - 01/2013
2Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2013 - 01/2011
2Biomarkers (Surrogate Marker)IBA
10/2013 - 11/2011
2Doxorubicin (Adriamycin)FDA LinkGeneric
10/2013 - 08/2003
2BilirubinIBA
07/2013 - 09/2003
2Buprenorphine (Subutex)FDA LinkGeneric
03/2013 - 01/2009
2Opioid Analgesics (Opioids)IBA
03/2013 - 01/2009
2namitecanIBA
12/2012 - 07/2012
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
09/2012 - 07/2006
2AEE 788 (AEE788)IBA
09/2012 - 10/2010
23- (4'- hydroxy- 3'- adamantylbiphenyl- 4- yl)acrylic acidIBA
08/2012 - 03/2007
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2012 - 10/2010
2Type I DNA Topoisomerases (Topoisomerase I)IBA
07/2012 - 02/2006
2ST 1481 (Gimatecan)IBA
09/2010 - 10/2005
2Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
12/2006 - 07/2006
2tyrosine receptor (receptor, tyrosine)IBA
07/2006 - 10/2005
1Histones (Histone)IBA
02/2021
1OTX015IBA
02/2021
1Biological ProductsIBA
01/2021
1AZD 6244IBA
01/2021
1TropomyosinIBA
01/2021
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
01/2021
1trkA ReceptorIBA
01/2021
1Telomerase (Telomerase Reverse Transcriptase)IBA
01/2021

Therapy/Procedure

20Therapeutics
02/2021 - 07/2003
14Drug Therapy (Chemotherapy)
01/2018 - 10/2002
6Radiotherapy
02/2015 - 10/2002
4Investigational Therapies (Experimental Therapy)
01/2014 - 06/2010
4Catheters
07/2010 - 04/2002
3Cryosurgery
11/2006 - 01/2003
3Catheter Ablation
03/2004 - 01/2003
2Radiofrequency Ablation
08/2003 - 11/2002